The Latest Breaking News from FDA

Coupled with the macroeconomic headwinds, the U.S. debt default crisis and consequent recessionary fears have triggered market volatility. Against this backdrop, quality growth stocks Boston Scientific (BSX), Cardinal Health (CAH), Cidara Therapeutics (CDTX), and Geospace Technologies (GEOS) could be solid buys now. Read on….

Karl Warburton, 43, died last May from xylazine, which is used by vets as a tranquilliser for large animals such as horses and cows - the drug has never been approved for human use as it can cause flesh-rotting sores on takers’ skin

Drug shortages in the US are forcing physicians and the public to scramble for access to vital medicines. While the problem isn’t new, the number of products in scarce supply is nearing an all-time high — and could get worse as generic drug makers pare back on the breadth of…

Opvee is similar to naloxone, the life-saving drug that has been used for decades to quickly counter overdoses of heroin, fentanyl and prescription painkillers.

U.S. health regulators have approved a new nasal spray to reverse overdoses due to fentanyl and other powerful opioids

The U.S. Food and Drug Administration approved a gene therapy for dystrophic epidermolysis bullosa, also known as butterfly disease.

The Centres for Disease Control and Prevention (CDC) confirmed the number of patients treated for the drug-resistant strain of Pseudomonas aeruginosa has now risen to 81 patients in 18 states

The FDA-licensed drug could be approved for use in the UK by the end of the year

The FDA’s updated food code, restaurants should have signs saying dogs are welcome and should develop plans to handle dogs and their waste. They should provide separate food bowls so dogs don’t use plates or utensils meant for humans.